Cantor Fitzgerald biotech analysts issued a rare and scathing note criticizing Health and Human Services Secretary Robert F. Kennedy Jr, according to Bloomberg. The note followed the abrupt resignation of FDA official Peter Marks. Analysts Josh Schimmer and Eric Schmidt urged the Trump administration to “re-evaluate” Kennedy’s leadership, saying he is steering the country “into dangerous territory” with views that undermine vaccine safety. The analysts described Marks’ ouster as a “clear condemnation” of HHS leadership and called for action, expressing confidence that the administration could course-correct.
Category
🗞
NewsTranscript
00:00It's Benzinga, bringing Wall Street to Main Street.
00:02Federal biotech analyst issued a rare and scathing note criticizing
00:06Health and Human Services Secretary Robert F. Kennedy, Jr., that according to Bloomberg,
00:10the note filed the abrupt resignation of FDA official Peter Marks.
00:14Analysts Josh Schimmer and Eric Schmidt urged the Trump administration to
00:18re-evaluate Kennedy's leadership, saying he is steering the country into dangerous territory
00:24with views that undermine vaccine safety.
00:27Analysts described Marks' ouster as a clear condemnation
00:30of HHS leadership and called for action,
00:33expressing confidence that the administration could course correct.